Defining Regrettable Substitution
‘Regrettable substitution’ is a term used in environmental chemistry and toxicology to describe the pattern in which a hazardous chemical is replaced by a structurally related compound that was selected for its ability to replicate the original compound’s industrial function — but that turns out to share or present new versions of the original hazard. The concept was formalized in the context of flame retardants (PBDEs replaced by organophosphate esters) and plasticizers (bisphenol A replaced by bisphenol S and F), but it is arguably most thoroughly documented in the PFAS family.
The mechanism is straightforward: regulatory restriction of a specific PFAS compound creates market pressure to identify substitutes. Substitutes are evaluated primarily on technical performance and, to varying degrees, on the specific hazard criteria that triggered restriction of the original compound. Hazard criteria tend to lag science. By the time a substitute is characterized sufficiently to be restricted in turn, it has typically been in use for years, has contaminated new water sources, and has driven the development of yet another generation of replacements.
From PFOS to PFBS: The Sulfonate Substitution Timeline
PFOS (C8 sulfonate) was restricted under the Stockholm Convention in 2009 following documentation of global environmental contamination and human health effects. Its primary replacement in many applications was PFBS (C4 sulfonate), marketed as less bioaccumulative due to its shorter chain length and faster renal clearance in animals. PFBS was introduced as a high-production-volume replacement that could perform similarly to PFOS in surfactant formulations.
What PFBS shares with PFOS is environmental persistence: both are resistant to microbial degradation and chemical hydrolysis under environmental conditions. PFBS has now been detected in drinking water sources worldwide, including U.S. public water systems monitored under UCMR 5. Toxicological studies have identified thyroid disruption effects for PFBS in animal models. The EPA has included PFBS in its MCL hazard index framework. The regulatory cycle that began with PFOS has followed PFBS — but the treatment infrastructure built around PFOS removal (GAC) addresses PFBS poorly.
From PFOA to GenX: The Carboxylate Substitution Timeline
PFOA (C8 carboxylate) was phased out under the EPA’s 2006 PFOA Stewardship Program. Its replacement in fluoropolymer manufacturing emulsions was, in part, GenX (HFPO-DA) — a short-chain ether-containing PFCA that could function as a polymerization processing aid without the long-chain fluorocarbon backbone that had attracted regulatory concern. Chemours (formerly a DuPont unit) marketed GenX under the trade name Capstone.
By 2017, GenX had been detected at elevated concentrations in the Cape Fear River downstream of the Fayetteville Works facility. Subsequent toxicological characterization found that GenX caused liver tumors in rodents and presented developmental and immune effects at environmentally relevant doses. The EPA included GenX in its 2024 MCL rule — approximately 15 years after its introduction as a ‘safer’ PFOA replacement. During that interval, it was not required in any filter certification testing.
Implications for Treatment System Design
The regrettable substitution cycle creates a structural problem for treatment engineering: treatment systems designed around the compound profile of current regulatory concern will be progressively overtaken by replacement compounds that were specifically engineered to have different chemical properties — and which, by extension, behave differently in the treatment systems deployed to address their predecessors.
Designing resilient PFAS treatment systems in this environment requires anticipating structural diversity rather than optimizing for a fixed compound list. Technologies that work through mechanisms less sensitive to specific molecular structure — particularly high-pressure membranes and certain advanced oxidation processes — offer more durable protection against an evolving compound portfolio than adsorption-based systems whose performance is tightly coupled to the specific molecular properties of the compounds they were calibrated against.